Search research articles
Contact Us
Filters
Showing results (771-780 of 945) with videos related to
Page
of 95
Sort By:
The Veterinary Record
|
August 30, 2008
Time for a rethink on the ban on swill feeding?
R H C Penny, R M S Cockburn, A J Harding, et al.
Cancer Medicine
|
August 26, 2020
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
Imane El Dika, Marinela Capanu, Joanne F Chou, et al.
Phytochemistry
|
May 1, 2023
Schomburginones A‒J, geranylated benzophenones from the leaves of Garcinia schomburgkiana and their cytotoxic and anti-inflammatory activities
Edwin R Sukandar, Sutin Kaennakam, Sutthida Wongsuwan, et al.
The New England Journal of Medicine
|
November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatment
Margaret K Callahan, Raajit Rampal, James J Harding, et al.
Journal of Medicinal Chemistry
|
December 27, 2021
Correction to "Structure-Activity Relationship of USP5 Inhibitors"
Mandeep K Mann, Carlos A Zepeda-Velázquez, Héctor González-Álvarez, et al.
Nature Geoscience
|
January 10, 2022
Regulation of ionospheric plasma velocities by thermospheric winds
Thomas J Immel, Brian J Harding, Roderick A Heelis, et al.
Brain Imaging and Behavior
|
December 17, 2014
Anterior cingulate dopamine turnover and behavior change in Parkinson's disease
Catherine L Gallagher, Brian Bell, Matthew Palotti, et al.
Scientific Reports
|
October 21, 2017
Gut microbiome alterations in Alzheimer's disease
Nicholas M Vogt, Robert L Kerby, Kimberly A Dill-McFarland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma
James J Harding, Ghaith Abu-Zeinah, Joanne F Chou, et al.
Journal of Medicinal Chemistry
|
October 14, 2021
Structure-Activity Relationship of USP5 Inhibitors
Mandeep K Mann, Carlos A Zepeda-Velázquez, Héctor González-Álvarez, et al.
Page
of 95
Search research articles
Search
Showing results (771-780 of 945) with videos related to
Sort By:
Page
of 95
The Veterinary Record
|
August 30, 2008
Time for a rethink on the ban on swill feeding?
R H C Penny, R M S Cockburn, A J Harding, et al.
Cancer Medicine
|
August 26, 2020
Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
Imane El Dika, Marinela Capanu, Joanne F Chou, et al.
Phytochemistry
|
May 1, 2023
Schomburginones A‒J, geranylated benzophenones from the leaves of Garcinia schomburgkiana and their cytotoxic and anti-inflammatory activities
Edwin R Sukandar, Sutin Kaennakam, Sutthida Wongsuwan, et al.
The New England Journal of Medicine
|
November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatment
Margaret K Callahan, Raajit Rampal, James J Harding, et al.
Journal of Medicinal Chemistry
|
December 27, 2021
Correction to "Structure-Activity Relationship of USP5 Inhibitors"
Mandeep K Mann, Carlos A Zepeda-Velázquez, Héctor González-Álvarez, et al.
Nature Geoscience
|
January 10, 2022
Regulation of ionospheric plasma velocities by thermospheric winds
Thomas J Immel, Brian J Harding, Roderick A Heelis, et al.
Brain Imaging and Behavior
|
December 17, 2014
Anterior cingulate dopamine turnover and behavior change in Parkinson's disease
Catherine L Gallagher, Brian Bell, Matthew Palotti, et al.
Scientific Reports
|
October 21, 2017
Gut microbiome alterations in Alzheimer's disease
Nicholas M Vogt, Robert L Kerby, Kimberly A Dill-McFarland, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma
James J Harding, Ghaith Abu-Zeinah, Joanne F Chou, et al.
Journal of Medicinal Chemistry
|
October 14, 2021
Structure-Activity Relationship of USP5 Inhibitors
Mandeep K Mann, Carlos A Zepeda-Velázquez, Héctor González-Álvarez, et al.
Page
of 95